Kanaly Trust’s Integra LifeSciences IART Stock Holding History

Kanaly Trust’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$7K	Hold	170	–	–	﹤0.01%	606
2016 Q3	$7K	Hold	170	–	–	﹤0.01%	593
2016 Q2	$7K	Hold	170	–	–	﹤0.01%	593
2016 Q1	$6K	Hold	170	–	–	﹤0.01%	622
2015 Q4	$6K	Hold	170	–	–	﹤0.01%	636
2015 Q3	$5K	Sell	170 -38	-18%	-$1.19K	﹤0.01%	642
2015 Q2	$6K	Buy	+208	New	+$5.54K	﹤0.01%	619

Other funds holding IART

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Kanaly Trust's IART Position: Q4 2016 in Review

Kanaly Trust held its Integra LifeSciences (IART) position steady in Q4 2016 at 170 shares worth $7K. The position accounts for ﹤0.01% of the portfolio, ranked #606.

Kanaly Trust first reported a position in IART in Q2 2015 and has held it in 7 quarters since. 223 funds tracked by Wall St. Rank hold IART as of Q4 2016.

Kanaly Trust held 170 shares of Integra LifeSciences worth $7K as of Q4 2016.
Kanaly Trust left its Integra LifeSciences share count unchanged in Q4 2016.
Integra LifeSciences made up ﹤0.01% of Kanaly Trust's portfolio in Q4 2016, its #606 holding.
Kanaly Trust first reported a position in Integra LifeSciences in Q2 2015 and has held it in 7 quarters since.
223 funds tracked by Wall St. Rank held Integra LifeSciences as of Q4 2016.

Based on Kanaly Trust's 13F filing for Q4 2016, filed 23 Jan 2017.